Molecular profiling of human cancer

Nature Reviews Genetics

Volumn 1, Issue 1, 2000, Pages 48-56

  Liotta, Lance ^a   Petricoin, Emanuel ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR PROTEIN;

CLASSIFICATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LABORATORY DIAGNOSIS; NEOPLASM; REVIEW;

GENE EXPRESSION PROFILING; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; SPECIMEN HANDLING; TRANSCRIPTION, GENETIC;

EID: 0034303643     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/35049567     Document Type: Review

References (51)

1. Adams, M. D. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 377, 3-20 (1999).
2. Aparicio, S. A. J. R. How to count human genes. Nature Genet. 25, 129-130 (2000).
3. Hancock, W. et al. Integrated genomic/proteomic analysis. Anal. Chem. 71, 743-748 (1999).
4. Kohn, K. Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol. Biol. Cell 10, 2703-2734 (1999).
5. Pease, A. C. et al. Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc. Natl Acad. Sci. USA 91, 5022-5026 (1994).
6. DeRisi, J. et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet. 14, 457-460 (1996).
7. Lipshutz, R. et al. High density synthetic oligonucleotide arrays. Nature Genet. 21, S20-S24 (1999).
8. Singh-Gasson, S. et al. Maskless fabrication of light-directed oligonucleotide microarrays using a digital micromirror array. Nature Biotechnol. 17, 974-978 (1999).
9. Holland, J. F. et al. Cancer Medicine 5th Edn, Section I (Williams and Wilkins, New York, 1999).
10. Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000). Describes the application of DNA arrays to molecular profiling of patients with lymphoma. Large-scale transcriptional profiling, coupled with pattern recognition algorithms, reveals previously unknown gene expression patterns that divide patients into two main groups - high and low ten-year survival.
11. Golub, T. R. et al. Molecular classiffication of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999). A generic approach to cancer classification is proposed on the basis of gene expression monitoring using DNA arrays. Transcript profiling is used to distinguish acute myeloid leukaemia from acute lymphoblastic leukaemia.
12. Ross, D. T. et al. Systematic variation in gene expression patterns in human cancer cell lines. Nature Genet. 24, 227-235 (2000).
13. Perou, C. M. et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA 96, 9212-9217 (1999).
14. Perou, C. M. et al. Molecular portraits of human breast tumors. Nature 406, 747-752 (2000). DNA arrays are used to develop a molecular portrait of individual patient's breast cancers. The gene expression pattern of a tumour was correlated with the microscopic characteristics of the tumour and some were followed before and after treatment.
15. Bittner, M. et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536-540 (2000). Global transcript analysis is used to show that subsets of human melanomas have distinct phenotypic characteristics.
16. Sgroi, D. et al. In vivo gene expression profile analysis. Cancer Res. 59, 5656-5661 (1999).
17. Goldsworthy, S. M. et al. Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue. Mol. Carcinogenesis 25, 86-91 (1999).
18. Paweletz, et al. (SELDI) Biomarker profiling of stages of cancer progression directly from human tissue using a protein biochip. Drug Devel. Res. 49, 34-42 (2000).
19. Kononen, J. et al. Tissue microarrays for high throughput molecular profiling of tumor specimens. Nature Med. 4, 844-647 (1998). Technology is described to array hundreds of small pieces of individual tumours on a single microscopic slide. The result is a high-throughput means to screen a marker on hundreds of tumour samples at once.
20. Ornstein, D. et al. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 21, 2235-2242 (2000).
21. Emmert-Buck, M. R. et al. Laser capture microdissection. Science 274, 998-1001 (1996). Technology is described for sampling the macromolecules of tissue cells under microscopic visualization. The extracted DNA, RNA or protein of pure tissue cells can be applied to DNA, RNA or protein profiling arrays.
22. Simone, N. L. et al. Laser capture microdissection: Opening the microscopic frontier to molecular analysis. Trends Genet. 14, 272-276 (1998).
23. Luo, L. et al. Gene expression profiles of laser-captured adjacent neuronal subtypes. Nature Med. 5, 117-122 (1999).
24. Perrone, E. E. et al. Tissue microarray assessment of prostate cancer tumor proliferation in african american and white men. J. Natl Cancer Inst. 92, 937-939 (2000).
25. Clark, E. A., Golub, T., Lander, E. & Hynes, R. Genomic analysis of metastasis reveals an essential role to RhoC. Nature 406, 532-535 (2000). DNA arrays are used to study the switch from a locally growing tumour to a metastatic form. This approach revealed an important role for RhoC, a small GTPase, which may influence invasion.
26. Leethanakul, C. et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19, 3220-3224 (2000).
27. Cole, K. A. et al. The genetics of cancer - A 3D mode. Nature Genet. 21, 38-41, (1999).
28. Humphery-Smith, I. Cordwell, S. J. & Blackstock, W. P. Proteome research: Complementarity and limitations with respect to the RNA and DNA worlds. Electrophoresis 18, 1217-1242 (1997).
29. Gygi, S. P. et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnol. 17, 994-999 (1999).
30. Buckholz, R. et al. Automation of yeast two-hybrid screening. J. Mol. Microbiol. Biotechnol. 1, 135-140 (1999).
31. Page, M. J. et al. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proc. Natl Acad. Sci. USA 96, 12589-12594 (1999).
32. Banks, R. E. et al. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis. Electrophoresis 20, 689-700 (1999).
33. Emmert-Buck, M. et al. An approach to the proteomic analysis of human tumors. Mol. Carcinogen. 27, 158-165 (2000).
34. Arenkov, P. et al. Protein microchips: Use for immunoassay and enzymatic reactions. Anal. Biochem. 278, 123-131 (2000). Protein array technology is described in which antibodies, antigens and enzymes are immobilized in a miniature array. This is an example of technology that could be applied to the identification of protein profiles associated with cancer type or clinical response.
35. Ekins, R. & Chu, F. W. Multianalyte microspot immunoassay-microanatytical 'compact disk' of the future. Clin. Chem. 37, 1955-1967 (1991).
36. Mendoza, L. G. et al. High throughput microarray based enzyme linked immunosorbant assay. BioTechniques 27, 778-768 (1999).
37. Rowe, C. A. et al. Array biosensor for simultaneous identification of bacterial, viral, and protein analytes. Anal. Chem. 71, 3846-3852 (1999).
38. Chiem, N. H. & Harrison, D. J. Microchip systems for immunoassay: an integrated immunoreactor with electrophoretic separation for serum theophylline determination. Clin. Chem. 44, 591-598 (1998).
39. Ekins, R. & Chu, R. W. in Principals and Practices of Immunoassays 2nd edn 625-646 (eds Price, C. P. & Newman, D. J.) (Stockton, New York, 1997).
40. Lueking, A. et al. Protein microarrays for gene expression and antibody screening. Anal. Biochem. 270, 103-111 (1999).
41. Silzel, J. W. et al. Mass-sensing multianalyte microarray immunoassay with imaging detection. Clin. Chem. 44, 2036-2043 (1998).
42. Jones, V. W. et al. Microminiaturized immunoassays using atomic force microscopy and compositionally patterned antigen arrays. Anal. Chem. 70, 1233-1241 (1998).
43. Vasiliskov, V. et al. Fabrication of microarray of gel-immobilized compounds on a chip by copolymerization. BioTechniques 27, 592-606 (1999).
44. Wadkins, R. M. et al. Biosensors and bioelectronics: detection of multiple toxic agents using a planar array. Immunosensor 13, 407-415 (1998).
45. Shriver-Lake, L. C. Ogert, R. A. & Ligler, F. S. A fiber optic evanescent-wave immunosensor for large molecules. Sensors Actuators 11, 239-243 (1993).
46. Narang, U., Gauger, P. R., Kusterbeck, A. W. & Ligler, F. S. Multianalyte detection using a capillary-based flow immunosensor. Anal. Biochem. 255, 13-19 (1998).
47. Carson, R. T. & Vignali, D. A. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J. Immunol. Methods 227, 41-52 (1999).
48. Fulton, R. J. et al. Advanced multiplexed analysis with the flowMetrix system. Clin. Chem. 43, 1749-1756 (1997).
49. Hunter, T. Signaling: 2000 and beyond. Cell 100, 113-127 (2000).
50. Pawson, T. Protein modules and signalling networks. Nature 373, 573-580 (1995).
51. Croix, B. et al. Genes expressed in human tumor endothelium. Science 289, 1197-1202 (2000).